Charles Zeller, DO
Otolaryngology · Deerfield Beach, FLNPI 1720086366
Payments from drug & device makers
Across 68 payments — averaging $127.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$3K
- Inspire Medical Systems, Inc.$1K
- Stryker$631
- Medical Device Business Services, Inc.$402
- Optinose US, Inc.$311
- Pacira Pharmaceuticals Incorporated$251
- plus $2K from 25 others
What the payments were for
- Speaking & faculty fees$3,02435%
- Travel & lodging$1,02012%
- Food & beverage$4,60053%
- Gifts$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 4 | $3,208 |
| Inspire Medical Systems, Inc. | 7 | $1,363 |
| Stryker | 9 | $631 |
| Medical Device Business Services, Inc. | 3 | $402 |
| Optinose US, Inc. | 6 | $311 |
| Pacira Pharmaceuticals Incorporated | 2 | $251 |
| Acclarent, Inc | 5 | $193 |
| Atricure, Inc. | 1 | $166 |
| Innovation Technologies Inc | 1 | $159 |
| Acumed LLC | 1 | $158 |
| Cumberland Pharmaceuticals, Inc. | 2 | $149 |
| Davol Inc. | 2 | $141 |
| Eagle Pharmaceuticals, Inc. | 1 | $128 |
| Acell, Inc. | 1 | $125 |
| AstraZeneca | 1 | $125 |
| Merck | 1 | $125 |
| CSL Behring | 1 | $123 |
| Medtronic | 1 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $118 |
| KCI USA, Inc. | 1 | $113 |
| Intuitive Surgical | 1 | $100 |
| Atos Medical Inc | 1 | $78 |
| Smith+Nephew | 2 | $67 |
| Sanofi | 3 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| Intersect ENT, Inc. | 2 | $46 |
| Aroa Biosurgery Incorporated | 1 | $39 |
| Alk-abello, Inc | 2 | $30 |
| Si-bone, Inc. | 1 | $29 |
| GSK | 1 | $20 |
| Aerin Medical Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$3,000
- Inspire Upper Airway Stimulation System$1,020
- Iovera$251
- Xhance$249
- SPINEJACK$167
- ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$166
- Irrisept$159
- RibLoc$158
- Inspire$145
- CASCADIA INTERBODY SYSTEM$141
- ENTELLUS - XPRESS ENT DILATION SYSTEM$141
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$137
- BARHEMSYS$128
- Phasix Mesh$127
- BRIDION$125
- ANDEXXA$125
- Caldolor$125
- Kcentra$123
- NUVENT$122
- GATTEX$118
How this compares
$8,656 in reported general payments places this provider in the 85th percentile of 586 otolaryngology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XhanceFluticasone Propionate | 15 | $11,103 |
| Fluticasone Propionate | 149 | $2,306 |
| Azelastine Hcl | 69 | $1,600 |
| Fluocinolone Acetonide Oil | 32 | $1,570 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 20 | $1,235 |
| Mometasone Furoate | 20 | $1,090 |
| Ipratropium Bromide | 38 | $906 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 14 | $786 |
| Methylprednisolone | 54 | $387 |
| Desloratadine | 20 | $364 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $285 |
| Famotidine | 23 | $210 |
| Montelukast Sodium | 29 | $185 |
| Clindamycin Hcl | 20 | $162 |
| Pantoprazole Sodium | 24 | $105 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $311 | $11,10315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 586 otolaryngology providers in Florida.
Other otolaryngology in Deerfield Beach
- Craig ShapiroHollywood$8.1M
- Adrien EshraghiMiami$2.1M
- Cecelia DamaskOrlando$771K
- Ralph TufanoSarasota$733K
- Mitchell MillerClearwater$709K
- Brian KerrGainesville$629K
- Maria SuurnaMiami$456K
- Mark TaborTampa$348K
- Franklin RimellFort Myers$314K
- Tapan PadhyaTampa$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.